A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
Active, not recruiting · NCT05731271 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colorectal adenocarcinoma, metastatic neoplasm, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT05731271 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Transcenta Therapeutics (Hangzhou) Co., Ltd. | 6 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mary Crowley | Dallas | United States | 1 |
| NEXT Oncology | San Antonio | United States | 70 |
| OHSU | Portland | United States | 16 |